Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Douglas Shytle

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Aging Neuroscience|January 28, 2021
Propionate and Alzheimer's DiseaseJessica Killingsworth, Darrell Sawmiller, R Douglas Shytle
Cell Medicine|July 8, 2020
Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer's DiseaseMichael Leon, Darrell Sawmiller, R Douglas Shytle, et al.
Physiology & Behavior|July 11, 2012
Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyondPaul R Sanberg, Cecilia Vindrola-Padros, R Douglas Shytle
American Journal of Translational Research|March 19, 2011
Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance testAdam J Smith, Brian Giunta, R Douglas Shytle, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 14, 2002
A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorderR Douglas Shytle, Archie A Silver, Berney J Wilkinson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 11, 2003
Ziprasidone-induced oculogyric crisisAmaya E Ramos, R Douglas Shytle, Archie A Silver, et al.
Experimental and Clinical Psychopharmacology|February 28, 2002
Anxiolytic effects of mecamylamine in two animal models of anxietyMary B Newman, John J Manresa, Paul R Sanberg, et al.
American Journal of Translational Research|April 21, 2015
MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycleSeol-Hee Kim, Adam J Smith, Jun Tan, et al.
Molecular Pharmaceutics|August 18, 2011
Cocrystals of quercetin with improved solubility and oral bioavailabilityAdam J Smith, Padmini Kavuru, Lukasz Wojtas, et al.
Expert Review of Neurotherapeutics|July 1, 2016
Potential new complication in drug therapy development for amyotrophic lateral sclerosisSvitlana Garbuzova-Davis, Avery Thomson, Crupa Kurien, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Aging Neuroscience|January 28, 2021
Propionate and Alzheimer's DiseaseJessica Killingsworth, Darrell Sawmiller, R Douglas Shytle
Cell Medicine|July 8, 2020
Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer's DiseaseMichael Leon, Darrell Sawmiller, R Douglas Shytle, et al.
Physiology & Behavior|July 11, 2012
Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyondPaul R Sanberg, Cecilia Vindrola-Padros, R Douglas Shytle
American Journal of Translational Research|March 19, 2011
Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance testAdam J Smith, Brian Giunta, R Douglas Shytle, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 14, 2002
A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorderR Douglas Shytle, Archie A Silver, Berney J Wilkinson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 11, 2003
Ziprasidone-induced oculogyric crisisAmaya E Ramos, R Douglas Shytle, Archie A Silver, et al.
Experimental and Clinical Psychopharmacology|February 28, 2002
Anxiolytic effects of mecamylamine in two animal models of anxietyMary B Newman, John J Manresa, Paul R Sanberg, et al.
American Journal of Translational Research|April 21, 2015
MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycleSeol-Hee Kim, Adam J Smith, Jun Tan, et al.
Molecular Pharmaceutics|August 18, 2011
Cocrystals of quercetin with improved solubility and oral bioavailabilityAdam J Smith, Padmini Kavuru, Lukasz Wojtas, et al.
Expert Review of Neurotherapeutics|July 1, 2016
Potential new complication in drug therapy development for amyotrophic lateral sclerosisSvitlana Garbuzova-Davis, Avery Thomson, Crupa Kurien, et al.
Pageof 5